Why Retina Practices Have Outsized Administrative Burdens
Among ophthalmic subspecialties, retina stands out for the administrative complexity its billing and scheduling demands generate. A retina practice managing a population of age-related macular degeneration and diabetic retinopathy patients is, in effect, running a high-volume injection clinic alongside a diagnostic imaging operation and a surgical practice — all simultaneously, and largely under Medicare.
Anti-VEGF injections for AMD and diabetic macular edema require prior authorization from most commercial payers, and even for Medicare patients, the buy-and-bill model for drugs like Eylea, Lucentis, and Vabysmo creates a billing cycle that involves drug acquisition, administration, J-code billing, and coinsurance management that is distinct from most medical practice billing. Retina Today's 2025 practice survey found that prior authorization tasks alone consumed an average of 14 staff hours per physician per week in high-volume retina practices — a figure that exceeds the total administrative time of many primary care practices.
Scheduling High-Frequency Return Visits
The injection visit cadence for retinal disease patients creates a scheduling challenge that compounds over time. A patient receiving Eylea for wet AMD may be on a treat-and-extend protocol with visits every 8 to 16 weeks, while a patient with proliferative diabetic retinopathy may require monthly injections for an extended period. Tracking these intervals, coordinating imaging appointments with injection visits, managing recalls for patients who miss appointments, and navigating scheduling conflicts across a multi-physician practice is a substantial operational challenge.
VAs with retina practice experience can manage the injection scheduling queue systematically — pulling recall lists each morning, contacting patients due for their next visit, reconciling scheduling intervals with the physician's treatment protocol, and flagging patients who are overdue. This proactive recall management prevents the gap in treatment that can lead to vision loss and that creates medicolegal exposure for the practice.
The American Society of Retina Specialists' 2025 workforce report noted that 71% of retina practice administrators identified scheduling management for return patients as their highest-volume daily task — and one of the most difficult to delegate internally given the clinical nuances involved in treatment interval coordination.
Prior Authorization Management
Prior authorization for biologic medications is one of the most labor-intensive and time-sensitive administrative functions in retina care. A single prior authorization for an anti-VEGF agent may require submission of clinical documentation, imaging results, prior treatment history, and a letter of medical necessity — followed by payer review periods, potential peer-to-peer reviews, and appeals for denied requests. Managing this process for 30 to 50 active patients simultaneously is effectively a full-time role.
VAs trained in retina billing can track authorization status for every active patient, initiate renewals before existing authorizations expire, prepare peer-to-peer request documentation for physician review, and manage the appeals workflow for denied claims. Keeping authorizations current prevents treatment delays that affect both patient outcomes and practice revenue.
A retina practice participating in the 2025 ASRS operational benchmarking study reported reducing authorization-related treatment delays by 67% after implementing a dedicated VA for prior authorization management — a result that the practice attributed to the consistency and follow-through that a dedicated role provided compared to rotating the task among front-office staff.
Medicare Billing for Diagnostic Imaging and Surgery
Beyond injections, retina practices bill for optical coherence tomography, fluorescein angiography, fundus photography, vitreoretinal surgery, and scleral buckling procedures. Each category has distinct Medicare billing rules, technical versus professional component splits, and documentation requirements. Errors in retina billing are financially material because the procedures and drugs involved carry high reimbursement values — and high audit risk.
VAs supporting retina billing need to understand J-code drug billing, the global surgery billing period rules for vitreoretinal procedures, and the documentation requirements for diagnostic imaging services. Practices evaluating VA support for retina billing should confirm relevant billing experience and inquire about quality control processes for claim review.
Stealth Agents connects specialty practices with VAs experienced in complex medical billing and administrative coordination, including subspecialty eye care.
The Capacity Problem VAs Solve
Retina practices are not growing their clinical capacity — the supply of retina-trained ophthalmologists is limited and fellowship positions are competitive. What practices can control is their administrative efficiency, which directly affects how many patients a given number of physicians can serve. By offloading the scheduling, authorization, and billing workload to a capable VA team, retina practices can optimize clinical throughput without compromising care quality or burning out their clinical staff.
The financial returns are significant. Practices that have implemented dedicated VA support for retina-specific administrative functions report recovering an average of $80,000 to $120,000 in previously uncollected or delayed revenue in the first year — primarily through better AR management and authorization compliance.
Sources
- Retina Today, 2025 Retina Practice Administrative Survey, retinatoday.com
- American Society of Retina Specialists, 2025 Workforce and Operations Report, asrs.org
- Medical Group Management Association, 2025 Specialty Practice Cost Survey, mgma.com